On September 1, the website of the National Financial Regulatory Administration disclosed a regulatory approval from the Xiamen Bureau of the National Financial Regulatory Administration regarding Xiamen Bank Co.,Ltd. (601187.SH, "Xiamen Bank") for issuing capital instruments. The approval permits the bank to issue capital supplementary instruments with a value not exceeding 9 billion yuan.
The bank must strictly comply with relevant regulations including the Commercial Bank Capital Management Measures when issuing and managing capital instruments. Within the approved limit, the bank has the autonomy to determine specific instrument types, issuance timing, batches, and scale, with completion required within 24 months of approval.
The regulatory approval also stipulates that Xiamen Bank must provide a written report on the issuance details to the Xiamen Bureau of the National Financial Regulatory Administration within 10 working days after the completion of capital instrument issuance.
Furthermore, Xiamen Bank is required to formulate and continuously improve medium and long-term capital supplementary plans that align with its development strategy and operational management capabilities. The bank must strengthen capital management, enhance capital constraints, and ensure economical and effective use of capital.
According to public information, Xiamen Bank was established in November 1996 as a joint-stock commercial bank approved by the People's Bank of China. The bank went public on the Shanghai Stock Exchange main board in October 2020, becoming the first listed city commercial bank in Fujian Province. The bank collaborates with Shanghai Gold Exchange, China Merchants Bank, and Xiamen Housing Purchase Guarantee Company in conducting gold trading business, wealth management product custody services, and second-hand housing loan guarantee services.
As of September 2, 2025, Xiamen Bank's stock closed at 6.67 yuan per share, down 1.22%, with a market capitalization of 17.603 billion yuan.
Comments